Results 261 to 270 of about 48,847 (353)

[Experimental and initial clinical experiences with the new class Ib anti-arrhythmia agent barucainide].

, 1988
H Gülker, H Heuer, B Frenking, Wilhelm Haverkamp, Gerhard Hindricks, Bev Bozek, C Bremkes, Asche Kd, D Witthöft   +8 more
openalex  

Some of the next articles are maybe not open access.

Related searches:

Recent progress in the treatment of cancer in children

Ca-A Cancer Journal for Clinicians, 2021
Theodore W Laetsch
exaly  

[Classification of anti-arrhythmia drugs and their mechanism of action. Iatrogeny of anti-arrhythmia agents].

, 1992
Tuna Jl
openalex  

Anti-arrhythmia agents.

La Clinica terapeutica, 1977
G, Bracchi, F, Vezzoli
openaire   +1 more source

[Efficacy of anti-arrhythmia agents for the prevention of cardiac sudden death].

, 1985
Seiichi Toyama, Hana Ogura, Yoshiharu Maeda   +2 more
openalex  

Improving the outcome for children with cancer: Development of targeted new agents

Ca-A Cancer Journal for Clinicians, 2015
Peter C Adamson
exaly  

[Can sudden cardiac death be prevented by anti-arrhythmia agents?].

, 1990
Janse Mj
openalex  

Epithelial ovarian cancer: Evolution of management in the era of precision medicine

Ca-A Cancer Journal for Clinicians, 2019
Stephanie Lheureux, Marsela Braunstein, Amit M Oza   +2 more
exaly  

[Comparative clinical study of trimecaine and lidocaine as anti-arrhythmia agents in myocardial infarct].

, 1980
Riabokon' Os, Piotrovskiĭ Vk, Smirnova Eb, Metelítsa Vi, Mazur Na   +4 more
openalex  

New aspects of the clinical use of anti-arrhythmia agents with special reference to acute therapy of ventricular tachycardia (lidocaine vs. ajmaline).

, 1990
M Manz, R. Mletzko, Werner Jung, B Lüderitz   +3 more
openalex